Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Actinogen Medical
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
Today 8:30 EDT
From
Actinogen Medical
Via
GlobeNewswire
Tickers
ASX:ACW
Actinogen provides pivotal Alzheimer’s trial enrolment update and other business news
April 30, 2025
From
Actinogen Medical
Via
GlobeNewswire
Tickers
ASX:ACW
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.